If there ’s one thing we can trustMartin Shkrelito do , it ’s revolutionize the healthcare diligence . The disgraced pharmaceutical administrator is now behind a Web3 based drug discovery platform called Druglike , that seeks to increase the approachability of drug discovery through decentralized computing .
The pharmaceutical industry is a avid industry that cashes in on vulnerable universe and is in desperate pauperism of a rotation . But in a vicious machine of fate , the man that ’s concerned in that rotation is none other than Martin Shkreli . You may recall him as the guy who levy the price of a life - pull through drug by 5,000 % . The predatory pharmaceutical administrator also just of late finished a stint in prison . He ’s now the cofounder of a fresh fellowship called Druglike , which apparently appear to democratize the costs of drug discovery ( drug discovery is a subfield of pharmacology that seeks to describe new drug ) via decentralised computation .
“ We begin Druglike because in our experience , traditional drug discovery software is too difficult and expensive to expend , ” said Shkreli , cofounder of Druglike , ina public press release . “ Druglike will remove barrier to early - stage drug discovery , increase innovation and appropriate a wide group of contributor to share the rewards . Underserved and underfunded community , such as those focused on rare disease or in developing markets , will also benefit from admission to these tool . ”
Martin Shkreli was arrested in New York City in 2015 for securities fraud.Image: Andrew Burton (Getty Images)
Okay , so we have a shadowy ex - pharmaceutical executive known for doing theopposite of democratizingthe price of medicine connect forces with a digital infrastructure that does n’t even really exist yet … what could go wrong ? Druglike argues that an fair $ 1.3 billion is spend on the uncovering and development of a undivided FDA - approved drug , citing a2020 paperin the Journal of the American Medical Association , and that drug discovery typically occurs on swarm computing , which can cost various institution an usurious amount of money . This barrier to entry can gatekeep the industry from smaller companies and researchers . Druglike lay claim they can breakup the intensive computer work to different “ nodes ” via a “ blockchain - based ” connection .
What Druglike gets right is that the healthcare research industry is incredibly expensive and hard to give way into , meaning that pharmaceutical companies now have an bonus to recoup those costs however they want . But are we just go to disregard the fact that Martin Shkreli is a cofounder of this party ?
Martin ShkreliMedicationWeb3
Daily Newsletter
Get the best tech , science , and refinement news in your inbox daily .
News from the future , give up to your present .
You May Also Like
